Media Centre


VIPcheck: an agar-based assay for Aspergillus fumigatus azole susceptibility screening

November 28 2017

A 4-well agar plate assay (VIPcheck) that screens for azole resistance in Aspergillus fumigatus gives promising results even on mixed cultures and when used by non-experts. It may be useful for guiding initial antifungal treatment while awaiting MIC results
Read more

IMMY register new lateral flow immunoassay (IgG & IgM) for Coccidioides (Valley Fever)

November 16 2017

IMMY have registered a new lateral flow device (sona™) with the FDA, which delivers a result in only 30 minutes
Read more

Type 2 diabetes: a risk factor for acquisition of and increased mortality from cryptococcal disease

November 02 2017

Type 2 diabetes has recently emerged as a putative risk factor for cryptococcal infections. A recent study in mainland China by Yingfang Li and colleagues reported a cryptococcal disease prevalence of 0.21% (1 in 475) among diabetic hospital patients, suggesting that improved blood glucose control may be important in preventing infection.
Read more

Watch for influenza-associated aspergillosis (IAA) in critically ill patients

October 31 2017

Around 1 in 6 ICU patients with influenza has a co-infection, but fungal co-infections tend to be underdiagnosed despite being associated with poor outcomes. Radiological signs (cavitary lesions, nodules, air-crescent) and galactomannan testing can identify which patients are likely to benefit from antifungal therapy.
Read more

 < 1 2 3 4 >  Last ›